7
Clinical Trials associated with GS3-007aA Phase I Clinical Study of GS3-007a Dry Suspensions in Healthy Chinese Adults: Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Dose, Dose-Escalation, and Food Effect Study
This study consists of two parts: the first part is a single-dose escalating(SAD) and food effect (FE)study, and the second part is a multiple-dose (14-day) escalating(MAD) study. Both phases are designed as randomized, double-blind, dose-escalation, placebo-controlled clinical studies.
/ Not yet recruitingPhase 2 Phase II Clinical Study of Single Oral Administration of GS3-007a for Oral Suspension in the Diagnosis of AGHD: A Multicenter, Randomized, Open-Label, Three-Way Crossover Trial
The GS3-007a Growth Hormone Stimulation Test (GHST) will be compared with the Insulin Tolerance Test (ITT) in an open-label, randomized, three-way crossover trial. The trial will include subjects suspected to have adult growth hormone deficiency (AGHD) and a group of healthy control subjects.
/ Not yet recruitingPhase 2IIT Phase II Clinical Study of Single Oral Administration of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD): A Multicenter, Randomized, Open-Label, Three-Way Crossover Trial
100 Clinical Results associated with GS3-007a
100 Translational Medicine associated with GS3-007a
100 Patents (Medical) associated with GS3-007a
100 Deals associated with GS3-007a